Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Sociology of Health & Illness|October 11, 2022
The challenge of institutionalised complicity: Researching the pharmaceutical industry in the era of impact and engagementPaul A MartinEar, Nose, & Throat Journal|October 2, 2002
Schwannoma of the epiglottis: first report of a casePaul A Martin, Christopher A Church, George ChonkichPlos Medicine|July 6, 2026
Discordance in orphan drug approvals between the U.S. Food and Drug Administration and the European Medicines Agency: A retrospective observational analysisJin Ding, Michael M Hopkins, Paul A MartinRegenerative Medicine|May 1, 2007
Commercial development of stem cell technology: lessons from the past, strategies for the futurePaul A Martin, Catherine Coveney, Alison Kraft, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 9, 2008
Genotyping the future: scientists' expectations about race/ ethnicity after BiDilRichard Tutton, Andrew Smart, Paul A Martin, et al.Ear, Nose, & Throat Journal|October 23, 2003
Pigmented villonodular synovitis of the temporomandibular joint: a report of two casesChristopher A Church, Mark Rowe, Raymund Llaurado, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 9, 2008
Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patientsGeorge T H Ellison, Jay S Kaufman, Rosemary F Head, et al.Journal of Medical Virology|June 20, 2012
Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trialStephen K Tyring, Stephanie Plunkett, Anita R Scribner, et al.Nature Biotechnology|April 8, 2006
Putting pharmacogenetics into practiceMichael M Hopkins, Dolores Ibarreta, Sibylle Gaisser, et al.Pageof 1